Compugroup Medical Se Stock Price To Earning
| COP Stock | EUR 14.02 1.02 6.78% |
Compugroup Medical SE fundamentals help investors to digest information that contributes to Compugroup Medical's financial success or failures. It also enables traders to predict the movement of Compugroup Stock. The fundamental analysis module provides a way to measure Compugroup Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Compugroup Medical stock.
Compugroup |
Compugroup Medical SE Company Price To Earning Analysis
Compugroup Medical's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current Compugroup Medical Price To Earning | 35.30 X |
Most of Compugroup Medical's fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Compugroup Medical SE is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
| Competition |
Based on the latest financial disclosure, Compugroup Medical SE has a Price To Earning of 35.3 times. This is 27.53% higher than that of the Technology sector and 7.76% lower than that of the Health Information Services industry. The price to earning for all Germany stocks is 22.91% lower than that of the firm.
Did you try this?
Run Sync Your Broker Now
Sync Your BrokerSync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
| All Next | Launch Module |
Compugroup Fundamentals
| Return On Equity | 0.12 | |||
| Return On Asset | 0.033 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | 2.74 B | |||
| Shares Outstanding | 52.23 M | |||
| Shares Owned By Insiders | 50.30 % | |||
| Shares Owned By Institutions | 29.81 % | |||
| Price To Earning | 35.30 X | |||
| Price To Book | 2.99 X | |||
| Price To Sales | 1.76 X | |||
| Revenue | 1.03 B | |||
| Gross Profit | 411.46 M | |||
| EBITDA | 213.99 M | |||
| Net Income | 68.97 M | |||
| Cash And Equivalents | 44.29 M | |||
| Cash Per Share | 0.91 X | |||
| Total Debt | 587.08 M | |||
| Debt To Equity | 132.20 % | |||
| Current Ratio | 0.94 X | |||
| Book Value Per Share | 12.87 X | |||
| Cash Flow From Operations | 165.27 M | |||
| Earnings Per Share | 1.36 X | |||
| Target Price | 51.81 | |||
| Number Of Employees | 8.83 K | |||
| Beta | 1.07 | |||
| Market Capitalization | 2.34 B | |||
| Total Asset | 1.79 B | |||
| Z Score | 1.8 | |||
| Annual Yield | 0.01 % | |||
| Five Year Return | 0.99 % | |||
| Net Asset | 1.79 B |
About Compugroup Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Compugroup Medical SE's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Compugroup Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Compugroup Medical SE based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Compugroup Stock
Compugroup Medical financial ratios help investors to determine whether Compugroup Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Compugroup with respect to the benefits of owning Compugroup Medical security.